BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysacc…
Biotechnology
US, San Rafael [HQ]
BMRN/Financial Reporting
Income Statements
15 Sheets · Starting from 2023In Million USD. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 324.00 | 376.00 | 441.00 | 500.00 | 548.00 | 751.00 | 889.00 | 1,116.00 | 1,313.00 | 1,491.00 | 1,704.00 | 1,860.00 | 1,846.00 | 2,096.00 | 2,419.00 | |
|
EPS
|
- - | 1.99 | -0.48 | -0.95 | -1.28 | -0.92 | -1.07 | -3.80 | -0.67 | -0.44 | -0.13 | 4.75 | -0.35 | 0.76 | 0.89 | |
| Diluted in mil. | - - | 1.73 | -0.48 | -0.95 | -1.28 | -0.92 | -1.07 | -3.79 | -0.67 | -0.44 | -0.13 | 4.53 | -0.35 | 0.75 | 0.88 | |
|
Profit
|
258.00 | 305.00 | 357.00 | 408.00 | 452.00 | 621.00 | 737.00 | 907.00 | 1,071.00 | 1,175.00 | 1,344.00 | 1,336.00 | 1,375.00 | 1,612.00 | 1,842.00 | |
| Gross Margin | 79.70 | 81.32 | 80.96 | 81.66 | 82.54 | 82.72 | 82.92 | 81.23 | 81.59 | 78.86 | 78.91 | 71.82 | 74.52 | 76.92 | 76.15 | |
| Pre Tax | - - | -21.00 | -43.00 | -118.00 | -176.00 | -124.00 | -154.00 | -831.00 | -35.00 | -142.00 | -94.00 | -42.00 | -75.00 | 149.00 | 188.00 | |
| Profit Margin | 0.17 | -5.71 | -9.88 | -23.62 | -32.18 | -16.63 | -17.39 | -74.41 | -2.73 | -9.57 | -5.56 | -2.27 | -4.08 | 7.14 | 7.79 | |
| ETR | 186.22 | 1,057.74 | -23.40 | 3.32 | 0.08 | -7.29 | -11.04 | 24.17 | -226.25 | 45.89 | 74.85 | 2,129.91 | 14.96 | 5.36 | 11.09 | |
| Net | - - | 205.00 | -53.00 | -114.00 | -176.00 | -133.00 | -171.00 | -630.00 | -117.00 | -77.00 | -23.00 | 854.00 | -64.00 | 141.00 | 167.00 | |
| Profit Margin | -0.15 | 54.70 | -12.20 | -22.84 | -32.15 | -17.84 | -19.31 | -56.43 | -8.91 | -5.18 | -1.40 | 45.90 | -3.47 | 6.75 | 6.93 | |
| EBITDA | 21.00 | 8.00 | -31.00 | -91.00 | -118.00 | -137.00 | -287.00 | -192.00 | -71.00 | -100.00 | -22.00 | -5.00 | 48.00 | 159.00 | 261.00 | |
| EBITDA Margin | 6.72 | 2.15 | -7.24 | -18.36 | -21.66 | -18.34 | -32.28 | -17.23 | -5.46 | -6.72 | -1.31 | -0.31 | 2.60 | 7.61 | 10.83 | |
| Operating Income | 16.00 | - - | -33.00 | -110.00 | -156.00 | -92.00 | -110.00 | -803.00 | -14.00 | -123.00 | -125.00 | -96.00 | -60.00 | 57.00 | 157.00 | |
| Operating Margin | 5.06 | 0.14 | -7.68 | -22.01 | -28.44 | -12.37 | -12.44 | -71.94 | -1.12 | -8.28 | -7.36 | -5.17 | -3.25 | 2.75 | 6.51 | |
| Interest Income | 5.00 | 4.00 | 2.00 | 2.00 | 3.00 | 5.00 | 4.00 | 7.00 | 14.00 | 22.00 | 22.00 | 16.00 | 10.00 | 18.00 | 58.00 | |
| Loss | -308.00 | -369.00 | -473.00 | -610.00 | -704.00 | -911.00 | -1,171.00 | -1,321.00 | -1,453.00 | -1,664.00 | -1,829.00 | -1,956.00 | -1,928.00 | -2,054.00 | -2,261.00 | |
| Cost of Revenue | -65.00 | -70.00 | -84.00 | -91.00 | -95.00 | -129.00 | -152.00 | -209.00 | -241.00 | -315.00 | -359.00 | -524.00 | -470.00 | -483.00 | -577.00 | |
|
Operating Expenses
|
-242.00 | -299.00 | -389.00 | -519.00 | -608.00 | -781.00 | -1,019.00 | -1,111.00 | -1,211.00 | -1,349.00 | -1,470.00 | -1,432.00 | -1,458.00 | -1,570.00 | -1,684.00 | |
| R&D | -115.00 | -147.00 | -214.00 | -302.00 | -354.00 | -461.00 | -634.00 | -661.00 | -610.00 | -696.00 | -715.00 | -628.00 | -628.00 | -649.00 | -746.00 | |
| G&A | -124.00 | -151.00 | -175.00 | -198.00 | -235.00 | -302.00 | -402.00 | -476.00 | -554.00 | -604.00 | - - | -334.00 | -354.00 | -403.00 | -448.00 | |
| SG&A | -124.00 | -151.00 | -175.00 | -198.00 | -235.00 | -302.00 | -402.00 | -476.00 | -554.00 | -604.00 | -680.00 | -737.00 | -759.00 | -854.00 | -937.00 | |
| S&M | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -403.00 | -405.00 | -450.00 | -488.00 | |
| Depreciation and Amortization | -20.00 | -27.00 | -36.00 | -45.00 | -47.00 | -56.00 | -47.00 | -96.00 | -87.00 | -95.00 | -105.00 | -105.00 | -108.00 | -101.00 | -104.00 | |
| Interest Expenses | -14.00 | -10.00 | -8.00 | -7.00 | -10.00 | -36.00 | -38.00 | -39.00 | -42.00 | -43.00 | -23.00 | -29.00 | -15.00 | -15.00 | -17.00 | |
| Other Expenses | -6.00 | -22.00 | -5.00 | -3.00 | - - | -66.00 | -160.00 | -594.00 | -131.00 | -51.00 | -30.00 | -53.00 | -15.00 | -92.00 | -30.00 | |
|
WA Shares Outstanding
|
100.00 | 103.00 | 112.00 | 120.00 | 137.00 | 145.00 | 160.00 | 165.00 | 174.00 | 177.00 | 179.00 | 180.00 | 182.00 | 185.00 | 187.00 | |
| Diluted | 100.00 | 125.00 | 112.00 | 120.00 | 137.00 | 146.00 | 160.00 | 166.00 | 174.00 | 177.00 | 179.00 | 191.00 | 182.00 | 188.00 | 191.00 |